US Pharm. 2009;34(9):8. 

Bethesda, MD -- The National Institute of Allergy and Infectious Diseases (NIAID) announced that an independent safety-monitoring committee has recommended that trials of a candidate 2009 H1N1 vaccine begin in children. Vaccinations will begin in two trials being conducted through NIAID's nationwide network of Vaccine and Treatment Evaluation Units (VTEU). The monitoring committee reviewed data from more than 500 healthy adult volunteers enrolled in three VTEU trials of candidate H1N1 vaccines that began on August 7, 2009, and found no safety concerns that would preclude trials in children.